UmanDiagnostics has entered a strategic partnership with Quanterix™
UmanDiagnostics has entered a strategic partnership with Quanterix™, a Boston based company digitizing biomarker analysis for precision health. The aim is to further develop UmanDiagnostics NF-light ELISA to enable blood analysis of traumatic brain injuries and neurodegenerative diseases. Combining superior antibodies with the most sensitive technology has the possibility to transform neurological diagnostics.
More information about UmanDiagnostics, please visit company home page